Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy.

Albanesi M, Nico A, Sinisi A, Giliberti L, Rossi MP, Rossini M, Kourtis G, Rucco AS, Loconte F, Muolo L, Zurlo M, Di Bona D, Caiaffa MF, Macchia L.

Clin Mol Allergy. 2018 Jan 18;16:2. doi: 10.1186/s12948-017-0079-y. eCollection 2018.


Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.

Di Bona D, Fiorino I, Taurino M, Frisenda F, Minenna E, Pasculli C, Kourtis G, Rucco AS, Nico A, Albanesi M, Giliberti L, D'Elia L, Caiaffa MF, Macchia L.

Respir Med. 2017 Sep;130:55-60. doi: 10.1016/j.rmed.2017.07.013. Epub 2017 Jul 19.


Experience with Canada's First Policy on Concussion Education and Management in Schools.

Hachem LD, Kourtis G, Mylabathula S, Tator CH.

Can J Neurol Sci. 2016 Jul;43(4):554-60. doi: 10.1017/cjn.2016.41. Epub 2016 May 4.


Retrospective monitoring in the management of persistent asthma.

Kourtis G, Caiaffa MF, Forte C, Scarlato MI, Macchia L.

Respir Care. 2011 May;56(5):633-43. doi: 10.4187/respcare.00796. Epub 2011 Jan 27.


Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak expiratory flow values before and after therapy.

Kourtis G, Rucco AS, Loconte F, Caiaffa MF, Macchia L.

J Investig Allergol Clin Immunol. 2010;20(5):451-2. No abstract available.


Skin testing technique and precision in stinging insect allergy.

Corallino M, Nico A, Kourtis G, Caiaffa MF, Macchia L.

J Clin Nurs. 2007 Jul;16(7):1256-64.


Supplemental Content

Loading ...
Support Center